LeonaBio, Inc. Short-term Lease, Cost
LeonaBio, Inc. (LONA) reported Short-term Lease, Cost of $3.00 thousand for the 3-month period ending 2021-09-30, per its 10-Q filed 2021-11-10.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ShortTermLeaseCost · last filed 2021-11-10
- LeonaBio, Inc. short-term lease, cost for the quarter ending 2021-09-30 was $3.00K, a 83.33% decline year-over-year.
- LeonaBio, Inc. short-term lease, cost for the quarter ending 2021-06-30 was $0.00, a 100.00% decline year-over-year.
- LeonaBio, Inc. short-term lease, cost for the quarter ending 2021-03-31 was $13.00K, a 51.85% decline year-over-year.
- LeonaBio, Inc. short-term lease, cost for the quarter ending 2020-12-31 was $19.00K.
- LeonaBio, Inc. short-term lease, cost for fiscal 2020 was $76.00K, a 21.65% decline from fiscal 2019.
- LeonaBio, Inc. short-term lease, cost for fiscal 2019 was $97.00K.
| Period end | Short-term Lease, Cost 3 month | Short-term Lease, Cost 6 month | Short-term Lease, Cost 9 month | Short-term Lease, Cost 12 month |
|---|---|---|---|---|
| 2021-09-30 | $3.00K 10-Q · filed 2021-11-10 | $3.00K derived: sum of 2 quarters · filed 2021-11-10 | $16.00K 10-Q · filed 2021-11-10 | $35.00K derived: sum of 4 quarters · filed 2021-11-10 |
| 2021-06-30 | $0.00 10-Q · filed 2021-08-16 | $13.00K 10-Q · filed 2021-08-16 | $32.00K derived: sum of 3 quarters · filed 2021-08-16 | $50.00K derived: sum of 4 quarters · filed 2021-11-10 |
| 2021-03-31 | $13.00K 10-Q · filed 2021-05-13 | $32.00K derived: sum of 2 quarters · filed 2021-05-13 | $50.00K derived: sum of 3 quarters · filed 2021-11-10 | $62.00K derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-12-31 | $19.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $37.00K derived: sum of 2 quarters · filed 2021-11-10 | $49.00K derived: sum of 3 quarters · filed 2021-11-10 | $76.00K 10-K · filed 2021-03-25 |
| 2020-09-30 | $18.00K 10-Q · filed 2021-11-10 | $30.00K derived: sum of 2 quarters · filed 2021-11-10 | $57.00K 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $12.00K 10-Q · filed 2021-08-16 | $39.00K 10-Q · filed 2021-08-16 | ||
| 2020-03-31 | $27.00K 10-Q · filed 2021-05-13 | |||
| 2019-12-31 | $97.00K 10-K · filed 2021-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |